IT1398781B1 - Oligonucleotidi, procedimento e kit per la rivelazione e quantificazione in real time pcr dell'espressione del gene mn1 come marcatore di malattia minima residua in pazienti affetti da leucemia mieloide acuta (lam) - Google Patents
Oligonucleotidi, procedimento e kit per la rivelazione e quantificazione in real time pcr dell'espressione del gene mn1 come marcatore di malattia minima residua in pazienti affetti da leucemia mieloide acuta (lam)Info
- Publication number
- IT1398781B1 IT1398781B1 ITTO2009A000685A ITTO20090685A IT1398781B1 IT 1398781 B1 IT1398781 B1 IT 1398781B1 IT TO2009A000685 A ITTO2009A000685 A IT TO2009A000685A IT TO20090685 A ITTO20090685 A IT TO20090685A IT 1398781 B1 IT1398781 B1 IT 1398781B1
- Authority
- IT
- Italy
- Prior art keywords
- mieloid
- revelation
- lam
- oligonucleotides
- leukemia
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- 230000001154 acute effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000032839 leukemia Diseases 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000011002 quantification Methods 0.000 title 1
- 238000003753 real-time PCR Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO2009A000685A IT1398781B1 (it) | 2009-09-07 | 2009-09-07 | Oligonucleotidi, procedimento e kit per la rivelazione e quantificazione in real time pcr dell'espressione del gene mn1 come marcatore di malattia minima residua in pazienti affetti da leucemia mieloide acuta (lam) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO2009A000685A IT1398781B1 (it) | 2009-09-07 | 2009-09-07 | Oligonucleotidi, procedimento e kit per la rivelazione e quantificazione in real time pcr dell'espressione del gene mn1 come marcatore di malattia minima residua in pazienti affetti da leucemia mieloide acuta (lam) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITTO20090685A1 ITTO20090685A1 (it) | 2011-03-08 |
| IT1398781B1 true IT1398781B1 (it) | 2013-03-18 |
Family
ID=41564189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITTO2009A000685A IT1398781B1 (it) | 2009-09-07 | 2009-09-07 | Oligonucleotidi, procedimento e kit per la rivelazione e quantificazione in real time pcr dell'espressione del gene mn1 come marcatore di malattia minima residua in pazienti affetti da leucemia mieloide acuta (lam) |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1398781B1 (it) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8206920B2 (en) * | 2007-03-26 | 2012-06-26 | Arnold Ganser | Diagnostic assay for the specific treatment of acute myeloid leukemia |
-
2009
- 2009-09-07 IT ITTO2009A000685A patent/IT1398781B1/it active
Also Published As
| Publication number | Publication date |
|---|---|
| ITTO20090685A1 (it) | 2011-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20240036I1 (fi) | Geeniterapia, joka ilmentää ihmisen hyytymistekijä IX:n muunnosta R338L | |
| BRPI0922688A2 (pt) | validação estatística de genes candidatos | |
| DK2417257T3 (da) | Tricyclo-dna-antisense-oligonukleotider, sammensætninger, og fremgangsmåder til behandlingen af sygdom | |
| EP2258369A4 (en) | PLASTER WITH MEDICAMENT PLASTER | |
| IL246697B (en) | Multiple exon skipping compositions for use in treating muscular dystrophy | |
| PT2367561E (pt) | Composições e métodos para o tratamento da doença celíaca | |
| HUE036780T2 (hu) | Új kompozíciók és eljárások immunológiai vonatkozású betegségek kezelésére | |
| BRPI0817437A2 (pt) | Implante cirúrgico com um recurso antirretrocesso | |
| BR112012006644A2 (pt) | composto,método de tratamento de um distúrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal, composição farmacêutica, uso de um composto e kit | |
| BRPI0913988A2 (pt) | conjunto e processo para prover um stent de implante | |
| DK2379018T3 (da) | Proteseovertræk | |
| BR112012006648A2 (pt) | composto,método de tratamento de um distúrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal, composição farmacêutica e kit | |
| BR112012006640A2 (pt) | composto, composição farmacêutica, método de tratamento de um distúrbio cognitivo, distúrbiopsocótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal e kit | |
| IL207641A0 (en) | Compositions comprising nucleic acids encoding vegf antagonists for use in treating ocular disease | |
| DE602007013699D1 (de) | Beschichtungszusammensetzungen mit verbesserter frühhärte | |
| BRPI0909416A2 (pt) | Utensílios médicos com revestimentos hidrofílicos | |
| BRPI0811623A2 (pt) | Métodos para identificar genes envolvidos na formação de memória usando pequeno rna interferente (sirna) | |
| JP2009215191A5 (it) | ||
| BRPI0908959A2 (pt) | aparelhos médicos com revestimentos hidrófilos | |
| SMT201600156B (it) | Trattamento dell’osteoartrite | |
| BRPI0921454A2 (pt) | métodos para tratar um paciente com câncer, e para identificar células tronco cancerosas | |
| DK2005182T3 (da) | Kliniske korrelater | |
| ITBO20080103A1 (it) | Microarray per l'analisi di sequenze nucleotidiche | |
| BRPI1013184A2 (pt) | método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral | |
| EP2299483A4 (en) | RIGGED DOUBLE SERVO NANO BREED |